About PMV Pharma
PMV Pharma is a company based in Cranbury (United States) founded in 2013 by Thomas Shenk and Arnold Levine. PMV Pharma has raised $236 million across 4 funding rounds from investors including Orbimed, RA Capital and Avoro Capital Advisors. The company has 47 employees as of December 31, 2024. PMV Pharma operates in a competitive market with competitors including Jazz Pharmaceuticals, C4 Therapeutics, Erasca, MiRagen and Mereo BioPharma, among others.
- Headquarter Cranbury, United States
- Employees 47 as on 31 Dec, 2024
- Founders Thomas Shenk, Arnold Levine
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Pmv Pharmaceuticals, Inc.
-
Annual Revenue
Not available
-
Net Profit
-$58.71 M (USD)14.87as on Dec 31, 2024
-
EBITDA
-$84.3 M (USD)-6.88as on Dec 31, 2024
-
Total Equity Funding
$236 M (USD)
in 4 rounds
-
Latest Funding Round
$70 M (USD), Series D
Aug 03, 2020
-
Investors
Orbimed
& 12 more
-
Employee Count
47
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of PMV Pharma
PMV Pharma is a publicly listed company on the NASDAQ with ticker symbol PMVP in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
People of PMV Pharma
Unlock access to complete
Unlock access to complete
Funding Insights of PMV Pharma
PMV Pharma has successfully raised a total of $236M across 4 strategic funding rounds. The most recent funding activity was a Series D round of $70 million completed in August 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in PMV Pharma
PMV Pharma has secured backing from 13 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Orbimed, RA Capital and Avoro Capital Advisors.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital fund focused on biotechnology startups
|
Locked | Locked | Locked | |
|
Investments are made by OrbiMed in global healthcare innovations across biopharmaceuticals and related fields.
|
Locked | Locked | Locked | |
|
PE firm investing in the US
|
Locked | Locked | Locked |
Investor details for PMV Pharma
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by PMV Pharma
Investment portfolio details for PMV Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - PMV Pharma
Detailed financials for PMV Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Pmv Pharma Comparisons
Peer comparison for PMV Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of PMV Pharma
PMV Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, C4 Therapeutics, Erasca, MiRagen and Mereo BioPharma, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| Locked | Locked | Locked |
Small-molecule drugs for cancer treatment are developed via Degronimid platform.
|
|
| Locked | Locked | Locked |
Small molecule therapeutics for cancer treatment are developed.
|
|
| Locked | Locked | Locked |
MicroRNA-based therapeutics are developed for treating multiple diseases.
|
|
| Locked | Locked | Locked |
Therapeutics for cancer and rare diseases are developed.
|
|
| Locked | Locked | Locked |
Targeted therapeutics for cancer, metabolic, and inflammatory diseases are developed.
|
Detailed competitors of PMV Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Pmv Pharma
Complete news archive for PMV Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about PMV Pharma
PMV Pharma was founded in 2013 and raised its 1st funding round 1 year after it was founded.
PMV Pharma is headquartered in Cranbury, United States. It is registered at Cranbury, New Jersey, United States.
David H Mack is the current CEO of PMV Pharma.
PMV Pharma is a funded company, having raised a total of $236M across 4 funding rounds to date.
As of Dec 31, 2024, the latest employee count at PMV Pharma is 47.
PMV Pharmaceuticals is a US-based, early-stage biotech developing p53 targeting small molecule therapeutics for cancer. The company was co-founded by Dr. Arnold Levine, one of the discoverers of the p53 protein. The protein, p53 plays a pivotal role in the bodys natural defense mechanism against cancer and induces a highly-organized program of cellular death to prevent the proliferation of potentially cancerous cells. The company hasnt disclosed its drug programs as of Aug.2017.
PMV Pharma's top competitors include Jazz Pharmaceuticals, C4 Therapeutics and Erasca.
Yes, PMV Pharma is publicly traded on NASDAQ under the ticker symbol PMVP.
PMV Pharma has 13 investors. Key investors include Orbimed, RA Capital, Avoro Capital Advisors, Wellington, and Nextech Invest.
The ticker symbol of PMV Pharma is PMVP on NASDAQ.